ID21755A - Antijamur azol yang mengandung ester asam amino - Google Patents

Antijamur azol yang mengandung ester asam amino

Info

Publication number
ID21755A
ID21755A IDW990505A ID990505A ID21755A ID 21755 A ID21755 A ID 21755A ID W990505 A IDW990505 A ID W990505A ID 990505 A ID990505 A ID 990505A ID 21755 A ID21755 A ID 21755A
Authority
ID
Indonesia
Prior art keywords
amino acid
antijamur
azol
acid esters
contains amino
Prior art date
Application number
IDW990505A
Other languages
English (en)
Indonesian (id)
Inventor
Lieven Meerpoel
Jan Heeres
Robert Josef Maria B Hendrickx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID21755A publication Critical patent/ID21755A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IDW990505A 1997-02-11 1998-02-03 Antijamur azol yang mengandung ester asam amino ID21755A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200374 1997-02-11
EP97203228 1997-10-15

Publications (1)

Publication Number Publication Date
ID21755A true ID21755A (id) 1999-07-22

Family

ID=26146124

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990505A ID21755A (id) 1997-02-11 1998-02-03 Antijamur azol yang mengandung ester asam amino

Country Status (31)

Country Link
US (3) US6262052B1 (cs)
EP (1) EP0958289B1 (cs)
JP (1) JP4347911B2 (cs)
KR (1) KR100509171B1 (cs)
CN (1) CN1238353C (cs)
AT (1) ATE270290T1 (cs)
AU (1) AU725302C (cs)
BG (1) BG63872B1 (cs)
BR (1) BR9809744A (cs)
CA (1) CA2262791C (cs)
CZ (1) CZ297197B6 (cs)
DE (1) DE69824834T2 (cs)
DK (1) DK0958289T3 (cs)
EE (1) EE03876B1 (cs)
ES (1) ES2224364T3 (cs)
HU (1) HU227744B1 (cs)
ID (1) ID21755A (cs)
IL (2) IL128513A (cs)
MY (1) MY129537A (cs)
NO (1) NO316668B1 (cs)
NZ (1) NZ334477A (cs)
PL (1) PL191152B1 (cs)
PT (1) PT958289E (cs)
RU (1) RU2197489C2 (cs)
SI (1) SI0958289T1 (cs)
SK (1) SK284910B6 (cs)
TR (1) TR199900584T2 (cs)
TW (1) TW495508B (cs)
UA (1) UA61919C2 (cs)
WO (1) WO1998034934A1 (cs)
ZA (1) ZA981079B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
AU1915500A (en) 1998-11-20 2000-06-13 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
EP1177192B1 (en) 1999-05-04 2003-03-19 Janssen Pharmaceutica N.V. Antifungal ethers
AU2002365077A1 (en) * 2001-09-19 2003-06-30 Massachusetts Institute Of Technology Methods and products related to non-viral transfection
ITMI20032020A1 (it) 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
JP6013326B2 (ja) * 2010-05-19 2016-10-25 サンド・アクチエンゲゼルシヤフト キラルトリアゾロンの調製のための方法
UA121562C2 (uk) 2014-12-30 2020-06-25 Дау Аґросаєнсиз Елелсі Сполуки аміду з фунгіцидною активністю
BR102019004480B1 (pt) * 2018-03-08 2023-03-28 Dow Agrosciences Llc Picolinamidas como fungicidas
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US4916134A (en) 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
NZ233502A (en) * 1989-06-09 1991-11-26 Janssen Pharmaceutica Nv 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
WO1993019061A1 (en) 1992-03-18 1993-09-30 Janssen Pharmaceutica N.V. Itraconazole and saperconazole stereoisomers
EP0736030B1 (en) * 1993-12-21 2001-08-29 Schering Corporation Tetrahydrofuran antifungals
SI0741737T1 (en) * 1994-01-24 2000-02-29 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
HUP9701690A3 (en) * 1995-06-02 1998-04-28 Schering Corp Kenilwort Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same
EP0837859B1 (en) 1995-06-19 2003-08-13 Schering Corporation Tetrahydrofuran antifungals

Also Published As

Publication number Publication date
HUP0001050A2 (hu) 2001-04-28
ES2224364T3 (es) 2005-03-01
NO316668B1 (no) 2004-03-29
EP0958289B1 (en) 2004-06-30
PT958289E (pt) 2004-11-30
DK0958289T3 (da) 2004-11-01
BR9809744A (pt) 2000-06-20
HU227744B1 (en) 2012-02-28
ATE270290T1 (de) 2004-07-15
SK105999A3 (en) 2000-06-12
SK284910B6 (sk) 2006-02-02
CZ297197B6 (cs) 2006-09-13
SI0958289T1 (en) 2004-12-31
US20030158210A1 (en) 2003-08-21
US6703506B2 (en) 2004-03-09
EE9900100A (et) 1999-10-15
TR199900584T2 (xx) 1999-10-21
DE69824834D1 (de) 2004-08-05
IL128513A (en) 2002-11-10
US20010039281A1 (en) 2001-11-08
IL149285A (en) 2007-08-19
KR20000068526A (ko) 2000-11-25
CN1238353C (zh) 2006-01-25
UA61919C2 (uk) 2003-12-15
HUP0001050A3 (en) 2001-07-30
CZ283599A3 (cs) 2000-02-16
DE69824834T2 (de) 2005-07-21
NO990484D0 (no) 1999-02-02
EE03876B1 (et) 2002-10-15
BG63872B1 (bg) 2003-04-30
ZA981079B (en) 1999-08-10
MY129537A (en) 2007-04-30
PL191152B1 (pl) 2006-03-31
US6262052B1 (en) 2001-07-17
CA2262791C (en) 2008-10-28
CA2262791A1 (en) 1998-08-13
BG103171A (en) 1999-09-30
PL332008A1 (en) 1999-08-16
NO990484L (no) 1999-10-11
AU6620798A (en) 1998-08-26
AU725302C (en) 2001-08-23
RU2197489C2 (ru) 2003-01-27
US6512116B2 (en) 2003-01-28
KR100509171B1 (ko) 2005-08-22
CN1236366A (zh) 1999-11-24
WO1998034934A1 (en) 1998-08-13
TW495508B (en) 2002-07-21
IL149285A0 (en) 2002-11-10
EP0958289A1 (en) 1999-11-24
JP4347911B2 (ja) 2009-10-21
AU725302B2 (en) 2000-10-12
NZ334477A (en) 2001-05-25
IL128513A0 (en) 2000-01-31
JP2001508080A (ja) 2001-06-19

Similar Documents

Publication Publication Date Title
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
MXPA02005536A (es) Acidos aminopropilfosfinicos novedosos.
AU8985391A (en) Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
ID21755A (id) Antijamur azol yang mengandung ester asam amino
TR200000737T2 (tr) İkame edilmiş kroman türevleri.
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
NZ332655A (en) Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
ITMI932189A1 (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
RS49520B (sr) Antimikrobno aktivne smeše
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
ES2094608T3 (es) Mezclas fungicidas.
ES8104271A1 (es) Procedimiento para la preparacion de 5-(2-((3-(1,3-benzodio-sol-5-il)-1-metilpropil)amino)-1-hidroxietil-2-metoxibenza- mida y de sus sales e isomeros opticos farmaceuticamente aceptables
NO931091L (no) Analoger av sykloinopeptid a og anvendelse derav